Mark Johnson: Elevating Patient and Warrior Voices During Sickle Cell Awareness Month
Mark Johnson, Sr. Medical Science Liaison at Agios Pharmaceuticals, shared Agios Pharmaceuticals‘ post on LinkedIn:
“Throughout Sickle Cell Awareness Month, we’ve shared stories about the unseen realities of living with sickle cell disease – from the silent physical damage of hemolysis to the emotional weight of isolation.
As we wrap up the month, Sophia, Cassandra, and Clifton’s story of connection reminds us why patient and warrior voices must always guide our work.
I’m proud to be part of a team that elevates these important stories and the warriors behind them.”
Agios Pharmaceuticals shared a post on LinkedIn:
“Living with Sickle Cell Disease can feel isolating – an emotional and often unseen reality.
For Sophia, suffering a stroke at just 13 years old led her to withdraw from the very community that understood her journey. But a chance to reconnect changed everything.
In this latest story, we see the profound power of connection. Reuniting with fellow Sickle Cell Warriors and meeting new members of the community through events as a young adult allowed Sophia to find a space where she felt truly seen as a person, not just a patient.
As we reach the end of Sickle Cell Awareness Month, we want to express our gratitude to every warrior, caregiver, and advocate who has shared stories with us. While September is ending, our commitment to elevating your voices, highlighting the unseen realities of living with sickle cell disease, and standing by the sickle cell community continues every single day.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series